View Older Stories View More Recent Stories

Dec 18, 2025 04:11AM Insmed (INSM) PT Lowered to $195 at Leerink Partners
Dec 18, 2025 03:53AM Insmed (INSM) PT Lowered to $167 at Wolfe Research
Dec 17, 2025 04:01PM Insmed discontinues nasal polyps drug program after trial fails
Dec 17, 2025 04:01PM Insmed (INSM) halted, news pending
Dec 16, 2025 06:48AM Insmed (INSM) PT Raised to $230 at Cantor Fitzgerald Brenso Potential
Dec 15, 2025 08:44AM Western Digital stock rises after inclusion in Nasdaq-100 Index
Dec 15, 2025 03:46AM Goldman Sachs Reiterates Buy Rating on Insmed (INSM)
Dec 10, 2025 09:24AM 'Insmed's (INSM) Quad Shot At Significant Upside'; PT Raised to $269 at TD Cowen
Dec 4, 2025 03:26AM Rothschild Redburn Starts Insmed (INSM) at Buy
Dec 1, 2025 05:35AM Insmed (INSM) PT Raised to $256 at Mizuho
Nov 18, 2025 11:00AM European Commission approves Insmed's BRINSUPRI for bronchiectasis
Nov 18, 2025 09:37AM Insmed (INSM) PT Raised to $227 at Leerink Partners
Oct 31, 2025 09:59AM Insmed (INSM) PT Raised to $223 at UBS
Oct 30, 2025 03:00PM Insmed (INSM) PT Raised to $223 at TD Cowen
Oct 30, 2025 07:11AM Insmed (INSM) Misses Q3 EPS by 41c, provide guidance
Oct 28, 2025 09:02AM Cantor Fitzgerald Assumes Insmed (INSM) at Overweight
Oct 20, 2025 09:44AM UBS Reiterates Buy Rating on Insmed (INSM)
Oct 17, 2025 07:01AM European regulators recommend Insmed's BRINSUPRI for rare lung disease
Oct 14, 2025 09:47AM Insmed (INSM) PT Raised to $194 at UBS
Oct 2, 2025 04:16AM Insmed (INSM) PT Raised to $193 at TD Cowen
Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
Sep 10, 2025 09:16AM RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes'
Sep 8, 2025 07:22AM Insmed (INSM) PT Raised to $172 at Guggenheim, 'continue to see it as a Top Pick'
Sep 3, 2025 05:20AM Cadence Design Systems (CDNS) Goldman Updates September Directors Cut Conviction List for US
Aug 20, 2025 04:28PM Insmed (INSM) PT Raised to $144 at Morgan Stanley
Aug 20, 2025 01:10AM William Blair Starts Insmed (INSM) at Outperform
Aug 14, 2025 11:06AM Insmed (INSM) PT Raised to $139 at Truist; 'We Remain Buyers'
Aug 14, 2025 06:48AM Insmed (INSM) PT Raised to $240 at H.C. Wainwright
Aug 14, 2025 06:04AM Insmed (INSM) PT Raised to $173 at Wolfe Research
Aug 14, 2025 05:55AM Insmed (INSM) PT Raised to $145 at Stifel
Aug 13, 2025 10:25AM Insmed (INSM) PT Raised to $154 at TD Cowen Following Brinsupri Approval
Aug 13, 2025 09:54AM RBC Capital on Insmed's (INSM) Brinsupri Approval: 'Stock PT To $138.00, Buyers Into The Launch'
Aug 13, 2025 06:38AM Insmed (INSM) PT Raised to $165 at Mizuho
Aug 13, 2025 05:21AM Insmed (INSM) PT Raised to $140 at Wells Fargo
Aug 13, 2025 05:19AM Insmed (INSM) PT Raised to $140 at UBS
Aug 13, 2025 01:58AM Morgan Stanley Downgrades Insmed (INSM) to Equalweight
Aug 12, 2025 02:49PM Insmed (INSM) PT Raised to $148 at Jefferies
Aug 12, 2025 11:36AM FDA approves BRINSUPRI as first treatment for non-cystic fibrosis bronchiectasis
Aug 12, 2025 10:15AM Insmed (INSM) Halted, News Pending
Aug 8, 2025 08:45AM Insmed (INSM) PT Raised to $120 at RBC Capital
Aug 7, 2025 04:10PM Insmed (INSM) PT Raised to $129 at Jefferies
Aug 7, 2025 07:05AM Insmed (INSM) Misses Q2 EPS by 40c
Jun 17, 2025 06:29AM Mizuho Reiterates Outperform Rating on Insmed (INSM), maintains as 'top June 2025 pick'
Jun 11, 2025 10:27PM Insmed (INSM) Announces Pricing of $750 Million Public Offering of Common Stock
Jun 11, 2025 04:01PM Insmed (INSM) Announces Proposed $650M Share Offering
Jun 11, 2025 09:15AM Insmed (INSM) PT Raised as RBC Capital Sees 'Continued Upside From Here'
Jun 11, 2025 06:37AM Insmed (INSM) PT Raised to $120 at H.C. Wainwright
Jun 11, 2025 06:36AM Insmed (INSM) PT Raised to $110 at Mizuho
Jun 11, 2025 05:41AM Insmed (INSM) PT Raised to $109 at BofA Securities
Jun 11, 2025 05:14AM Insmed (INSM) PT Raised to $110 at Evercore ISI
View More Recent Stories View Older Stories